Skip to content
Tenderpoints
Tenderpoints™Hub

Episode Notes

Source / episode info

  • Episode: 73
  • Title: Divine Intervention Episode 73 – Endocrine Physiology and Pharmacology Part 2 (Final Part)
  • Published: 2019-01-12
  • Source: Episode page

One-liner

This episode covers the pharmacology of anti-diabetic agents (Sulfonylureas, GLP-1 agonists, SGLT2 inhibitors), details the complex physiology and diagnostic testing for adrenal insufficiency using ACTH analogs and enzyme inhibitors (Metyrapone), and reviews growth hormone excess management.

High-yield summary

  • Adrenal Gland Structure: The cortex is organized into three zones: Glomerulosa (outermost, {Mineralocorticoids} -> Aldosterone); Fasciculata (middle, {Glucocorticoids} -> Cortisol); Reticularis (innermost, {Androgens}).
  • Sulfonylureas: These drugs stimulate insulin release by blocking ATP-sensitive potassium channels, leading to cell depolarization and calcium influx. They carry a high risk of hypoglycemia and are associated with sulfur allergies.
  • SGLT2 Inhibitors: Drugs like canagliflozin block the SGLT2 transporter in the proximal convoluted tubule, causing glucosuria (glucose loss in urine) and reducing blood glucose levels; they increase the risk of UT Is/genital infections.
  • Adrenal Insufficiency Workup: In primary adrenal insufficiency (Addison's disease), ACTH stimulation will fail to raise cortisol because the adrenal gland itself is damaged. The diagnostic test involves administering an ACTH analog (e.g., cosyntropin).
  • Metyrapone Mechanism: Metyrapone inhibits 11-hydroxylase, causing a predictable rise in {ACTH} and precursors ({11-deoxycortisol}) but a fall in cortisol, allowing differentiation of pituitary vs. adrenal failure.

Learning objectives

  • Differentiate the mechanisms of action and side effects of various anti-diabetic agents (Sulfonylureas, GLP-1 agonists, SGLT2 inhibitors).
  • Describe the normal physiological function and structural organization of the adrenal cortex and its hormones.
  • Interpret ACTH stimulation testing results to diagnose the site of adrenal insufficiency failure (primary vs. secondary/tertiary).
  • Understand the role of 11\beta-hydroxylase in cortisol synthesis and how inhibitors like Metyrapone alter the HPA axis feedback loop.
  • Recognize the clinical consequences of mineralocorticoid excess, such as those caused by licorice or chronic steroid use.

Board exam buzzwords

ConditionKey FindingAssociationBoard Exam Tip
Addison's Disease (Primary AI)Low Cortisol; High ACTHAutoimmune destruction of adrenal cortexThe failure to raise cortisol after cosyntropin injection confirms primary adrenal failure.
MetyraponeCortisol, 11-deoxycortisol, ACTH/CRHInhibits 11-hydroxylase (converts 11-deoxycorticosterone to corticosterone)Use this pattern to distinguish between pituitary failure ({ACTH} fails to rise) and adrenal failure.
SGLT2 InhibitorsGlucosuria; Blood GlucoseProximal convoluted tubule reabsorption blockadeRemember the risk of UT Is/genital infections, especially in diabetic patients.
Glucocorticoid Excess (Chronic Steroids)Osteoporosis, Purple Striae, Hypokalemic Metabolic AlkalosisConnective tissue degradation; Mineralocorticoid receptor agonismRequires prophylactic bisphosphonates and PP Is.

Rapid review table

TopicKey PointContextExam Relevance
SulfonylureasBlock K+ channels -> Depolarization -> Insulin releaseUsed for Type 2 Diabetes Mellitus (T2 DM)High risk of hypoglycemia; monitor insulin/C-peptide levels to differentiate from insulinoma.
GLP-1 AgonistsIncrease endogenous insulin secretion in response to glucose loadPreferred T2 DM agent classContraindicated in history of MTC/MEN2 due to animal data. Can cause weight loss (Liraglutide).
SGLT2 InhibitorsBlock reabsorption of {Na}^+/{Glucose} cotransporter in the proximal tubuleUsed for T2 DM; promotes glucosuriaCauses osmotic diuresis and increased risk of genital/UTI infections.
11-hydroxylase Inhibition (Metyrapone)Cortisol, 11-deoxycortisol, ACTHDiagnostic test for adrenal axis failureThe pattern helps localize the defect: if ACTH fails to rise, the problem is pituitary/hypothalamic.

Board-speak -> diagnosis

Board-speak / Vignette phraseDiagnosis / ConceptWhy it fits
A patient presents with fatigue, weight loss, and hypotension; ACTH stimulation test shows no rise in cortisol.Primary Adrenal Insufficiency (Addison's Disease)The failure to raise cortisol confirms the adrenal gland itself is unable to respond to ACTH, indicating primary failure.
A diabetic patient taking a sulfonylurea presents with severe hypoglycemia and has elevated insulin and C-peptide levels.Sulfonylurea-induced HypoglycemiaSulfonylureas stimulate endogenous insulin release by blocking K+ channels; thus, both endogenous markers (insulin/C-peptide) will be high.
A patient on chronic glucocorticoids develops hypokalemic metabolic alkalosis and hypertension.Mineralocorticoid Excess / Licorice ConsumptionGlucocorticoids can have mineralocorticoid activity. Inhibiting 11 HSD2 (e.g., with licorice/glyceritic acid) leads to elevated cortisol acting like aldosterone, causing K+ wasting and H+ retention.
A patient with a history of MEN syndrome or medullary thyroid cancer is being considered for GLP-1 agonist therapy.Contraindication: GLP-1 AgonistsDue to animal studies suggesting increased risk of medullary thyroid carcinoma (MTC) with these agents, they are contraindicated in patients with a history of MTC/MEN2.
A patient presents with polyuria and glucosuria; the urine osmolality is high, but serum osmolality is low.Syndrome of Inappropriate ADH Secretion (SIADH)This pattern indicates water retention relative to sodium loss ({Hypovolemic, hypotonic hyponatremia}). Treatment involves V2 receptor antagonists (e.g., tolvaptan).
A patient with chronic steroid use requires prophylaxis against bone loss and peptic ulcers.Bone/GI ProtectionChronic steroids cause osteoporosis and increase gastric acid secretion; therefore, bisphosphonates are used for bones, and PP Is are used for the stomach.

Differential diagnosis / distinguishing features

Metabolic Alkalosis Causes

Key FeaturesDistinguishing FindingsNext Step
Mineralocorticoid Excess (Licorice, high cortisol){Hypokalemia} + {Metabolic Alkalosis} + Hypertension.Treat the underlying cause; monitor K+ and Na+.
Carbonic Anhydrase Inhibitors/RTA Type 2Hypokalemic Non-Anion Gap Metabolic Acidosis (NAGMA).Correct electrolyte imbalance; consider specific antidotes or dietary changes.

Management pearls

  • For suspected adrenal insufficiency, always measure both cortisol and ACTH levels, as the pattern is diagnostic for primary vs secondary failure.
  • When initiating chronic steroid therapy, prophylactic use of bisphosphonates (for osteoporosis) and PP Is (for peptic ulcer disease/gastric acid suppression) is mandatory.
  • The diagnosis of SIADH should be confirmed by measuring urine osmolality relative to serum osmolality; treatment involves V2 receptor antagonists like tovaptan.
  • In the setting of chronic steroid use, a "stress dose" (higher than normal daily dose) must be administered when the patient is critically ill or undergoing surgery.

Don't miss

🚨
The adrenal cortex structure: Glomerulosa -> Mineralocorticoids; Fasciculata -> Glucocorticoids; Reticularis -> Androgens.
🚨
Metyrapone inhibits 11\beta-hydroxylase, leading to a predictable biochemical cascade (\downarrow Cortisol, \uparrow 11-deoxycortisol).
🚨
The primary mechanism of action for sulfonylureas is blocking the ATP-sensitive potassium channel, causing depolarization and insulin release.
🚨
Peghvisomant acts as a growth hormone receptor antagonist; its site of action is the liver (where IGF-1 is produced), leading to low circulating \text{IGF-1} levels.

Integration & clinical reasoning

  • Endocrine/Renal Integration: The mineralocorticoid effect of cortisol, especially when 11\beta HSD2 is inhibited (e.g., by licorice), can lead to sodium retention and potassium wasting, mimicking hyperaldosteronism.
  • Pharmacology/Metabolism Integration: Understanding the difference between \text{ACTH} analogs (\text{cosyntropin}) and enzyme inhibitors (\text{metyrapone}) is crucial for localizing endocrine axis defects.
  • GI/Endocrine Integration: The GI tract's ability to absorb glucose relies on secondary active transport via SGLT1 (gut) and SGLT2 (kidney), making these transporters key targets for diabetes drugs.

OMM / COMLEX integration

🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
  • Acute/Unstable Management Priority: In any patient presenting with signs of adrenal crisis (hypotension, shock, severe fatigue), standard emergency management (IV fluids, pressors) takes absolute priority over OMT. Glucocorticoids must be administered immediately.
  • GI Tract Focus: The understanding of SGLT1/SGLT2 transporters is relevant to GI fluid balance and osmotic diarrhea; the principles of secondary active transport are fundamental to gastroenterology.

Concept connections / cross-references

  • For detailed coverage of the adrenal gland structure, see [Episode 37].
  • For general principles of steroid pharmacology and side effects, review [Episode 45].
  • For comprehensive renal physiology including RTA types, see [Episode 62].

High-yield association table

ConditionAssociationMechanismClinical Significance
Addison's Disease{ACTH} stimulation test failureAutoimmune destruction of adrenal cortexRequires immediate replacement of both glucocorticoids and mineralocorticoids.
Metyrapone11-hydroxylase inhibitionBlocks conversion of 11-deoxycorticosterone to corticosteroneUsed diagnostically to differentiate pituitary vs. primary adrenal failure.
SGLT2 InhibitorsGlucosuria; {UTI} riskBlock SGLT2 in the proximal tubule, wasting glucose into urine.Excellent for T2 DM but requires caution in patients with renal impairment and increases infection risk.
PeghvisomantGrowth Hormone Receptor AntagonistBlocks GH action at the liver receptor siteUsed to treat acromegaly; low {IGF-1} levels confirm mechanism of action.

Key terms glossary

TermDefinitionContextExample
SulfonylureasOral hypoglycemic agents that stimulate endogenous insulin release by blocking K+ channels.Type 2 Diabetes Mellitus (T2 DM) management.Glyburide, Glipizide, Glimepiride.
11-hydroxylaseEnzyme responsible for converting {11-deoxycorticosterone} to corticosterone in the adrenal gland.Adrenal axis testing/Metyrapone mechanism.Inhibition by Metyrapone causes a predictable rise in ACTH and precursors.
SGLT2 InhibitorsDrugs that block the sodium-glucose cotransporter 2 in the proximal tubule.T2 DM management; promotes glucosuria.Canagliflozin, Empagliflozin.
CosyntropinSynthetic {ACTH} analog used diagnostically to test adrenal reserve.Workup of suspected primary adrenal insufficiency.If cortisol fails to rise after cosyntropin, the diagnosis is primary AI.

Study optimization

TopicStudy ApproachPriorityResources
Endocrine PharmacologyFocus on mechanism of action (MOA) and key side effects/contraindications for each drug class.HighReview tables comparing Sulfonylureas, GLP-1s, SGLT2is.
Adrenal Axis TestingMaster the interpretation of ACTH stimulation tests using Metyrapone or Cosyntropin.CriticalDraw out the HPA axis feedback loop and trace the effect of inhibitors/analogs.
Mineralocorticoid RegulationUnderstand how cortisol can mimic aldosterone activity (e.g., licorice, 11 HSD2 deficiency).ModerateReview electrolyte disturbances associated with mineralocorticoid excess ({Hypokalemia}, {Metabolic Alkalosis}).

Question pattern recognition

  • Pharmacology Mechanism: Identifying the specific molecular target and resulting physiological cascade (e.g., K+ channel block, receptor antagonism).
  • Diagnostic Testing Interpretation: Using biochemical testing results (ACTH/Cortisol levels) to localize a defect in a complex endocrine axis.
  • Electrolyte Derangements: Linking hormonal deficiencies or excesses (mineralocorticoid excess) to specific acid-base and electrolyte abnormalities (\text{Hypokalemia}, \text{Metabolic Alkalosis}).

Test yourself

Common mistakes to avoid

🚫
Confusing 11\beta-hydroxylase vs. 11\beta HSD2: Remember that 11\beta-hydroxylase is in the adrenal gland and is key for cortisol synthesis, while 11\beta HSD2 is primarily in the kidneys and converts active cortisol to inactive cortisone.
🚫
Misinterpreting \text{ACTH} response: Do not assume a low ACTH means pituitary failure; always test with an exogenous \text{ACTH} analog (cosyntropin) first to rule out primary adrenal destruction.
🚫
Assuming all diabetes drugs are safe: Remember the specific risks: Sulfonylureas (\text{Hypoglycemia}), GLP-1s (\text{MTC/MEN2} contraindication), SGLT2is (\text{UTI}).

Common traps

⚠️
The \text{ACTH} Trap (Pituitary vs. Adrenal): If the patient has low cortisol and high ACTH, they have primary AI. If they have low cortisol and low ACTH, they have secondary/tertiary AI. The key is to know which hormone level dictates the diagnosis.
⚠️
The \text{Metyrapone} Trap: When interpreting Metyrapone results, remember that if \text{CRH} rises but \text{ACTH} does not, the problem lies in the pituitary gland (pituitary failure).
⚠️
The Mineralocorticoid Trap: Do not forget that chronic steroid use or licorice ingestion can cause mineralocorticoid excess effects (\text{Hypokalemia}, \text{Metabolic Alkalosis}) even if the primary drug is a glucocorticoid.